T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
XYZ
Block, Inc.
XYZ
|
+$2.23B |
| 2 |
Carvana
CVNA
|
+$1.65B |
| 3 |
Microsoft
MSFT
|
+$1.46B |
| 4 |
Affirm
AFRM
|
+$1.2B |
| 5 |
Walt Disney
DIS
|
+$1.18B |
Top Sells
| 1 |
Visa
V
|
+$2.51B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.93B |
| 4 |
Salesforce
CRM
|
+$1.88B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.52B |
Sector Composition
| 1 | Technology | 25.2% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.81% |
| 5 | Financials | 12.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
United Therapeutics
UTHR
$18.3B
| $11.1M | ﹤0.01% |
60,234
-1,021
| -2% | -$188K |
|
1402
Innospec
IOSP
$2.05B
| $11.1M | ﹤0.01% |
131,684
-30,962
| -19% | -$2.61M |
|
|
GTHX
1403
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $11.1M | ﹤0.01% |
823,742
-3,847
| -0.5% | -$51.6K |
|
1404
Invitation Homes
INVH
$18.5B
| $11M | ﹤0.01% |
286,654
-23,200
| -7% | -$889K |
|
1405
CVRx
CVRX
$205M
| $10.3M | ﹤0.01% |
622,615
+22,615
| +4% | +$374K |
|
1406
Zscaler
ZS
$44.8B
| $10.2M | ﹤0.01% |
38,967
-901
| -2% | -$236K |
|
1407
Bentley Systems
BSY
$16.1B
| $10.2M | ﹤0.01% |
167,628
+33,434
| +25% | +$2.03M |
|
1408
Stitch Fix
SFIX
$714M
| $10.1M | ﹤0.01% |
252,264
+101,428
| +67% | +$4.05M |
|
|
INFN
1409
DELISTED
Infinera Corporation Common Stock
INFN
| $10M | ﹤0.01% |
1,203,562
-3,967
| -0.3% | -$33K |
|
1410
iShares Russell 1000 Growth ETF
IWF
$120B
| $10M | ﹤0.01% |
36,502
+5,985
| +20% | +$1.64M |
|
|
BNR
1411
Burning Rock Biotech
BNR
$89.4M
| $9.91M | ﹤0.01% |
55,448
-285
| -0.5% | -$51K |
|
1412
XPeng
XPEV
$19.9B
| $9.87M | ﹤0.01% |
+277,565
| New | +$9.87M |
|
1413
Syndax Pharmaceuticals
SNDX
$1.34B
| $9.86M | ﹤0.01% |
516,098
+95,678
| +23% | +$1.83M |
|
1414
Leggett & Platt
LEG
$1.3B
| $9.8M | ﹤0.01% |
218,525
-3,907
| -2% | -$175K |
|
1415
Solid Biosciences
SLDB
$420M
| $9.77M | ﹤0.01% |
272,557
-655
| -0.2% | -$23.5K |
|
1416
Bumble
BMBL
$710M
| $9.74M | ﹤0.01% |
194,822
-23,800
| -11% | -$1.19M |
|
1417
ATAI Life Sciences
ATAI
$992M
| $9.59M | ﹤0.01% |
648,074
-1,926
| -0.3% | -$28.5K |
|
1418
Seres Therapeutics
MCRB
$139M
| $9.47M | ﹤0.01% |
68,026
-1,366
| -2% | -$190K |
|
1419
Oxford Industries
OXM
$701M
| $9.39M | ﹤0.01% |
104,172
+97,658
| +1,499% | +$8.81M |
|
1420
Lyft
LYFT
$7.73B
| $9.3M | ﹤0.01% |
173,444
-137,264
| -44% | -$7.36M |
|
1421
Mersana Therapeutics
MRSN
$35.6M
| $9.25M | ﹤0.01% |
39,236
-53,474
| -58% | -$12.6M |
|
|
STOR
1422
DELISTED
STORE Capital Corporation
STOR
| $9.23M | ﹤0.01% |
288,123
-179,836
| -38% | -$5.76M |
|
1423
AMC Entertainment Holdings
AMC
$1.44B
| $9.23M | ﹤0.01% |
24,243
+2,391
| +11% | +$910K |
|
|
SQSP
1424
DELISTED
Squarespace, Inc.
SQSP
| $8.95M | ﹤0.01% |
231,681
-129,987
| -36% | -$5.02M |
|
|
SUMO
1425
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $8.9M | ﹤0.01% |
+552,011
| New | +$8.9M |
|